Viewing Study NCT06336265



Ignite Creation Date: 2024-05-06 @ 8:19 PM
Last Modification Date: 2024-10-26 @ 3:25 PM
Study NCT ID: NCT06336265
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-03-28
First Post: 2024-03-13

Brief Title: Diaphragmatic Ultrasound to Predict the Therapeutic Effect of High-flow Nasal Cannula Oxygen Therapy
Sponsor: Xingui Dai
Organization: First Peoples Hospital of Chenzhou

Study Overview

Official Title: Clinical Study of Diaphragmatic Ultrasound to Predict the Therapeutic Effect of High Flow Oxygen Therapy in Mild and Moderate Acute Hypoxic Respiratory Failure
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Follow-up was conducted for every patient requiring high-flow nasal cannula oxygen therapy in district 1 of the Intensive Care Department of Chenzhou NO1 Peoples Hospital Patients who met the inclusion criteria but did not meet the exclusion criteria were included for observation Respiratory parameters diaphragmatic activity and variation rate of diaphragmatic thickness were recorded at the beginning of high-flow nasal cannula oxygen therapy 1 hour after treatment 3 hours after treatment 6 hours after treatment 9 hours after treatment and 12 hours after treatment Throughout the procedure a panel of experts assessed whether the patient needed endotracheal intubation If yes the study was terminated if no high-flow nasal cannula oxygen therapy was continued and observation and evaluation were continued until the end point of the study 12 hours after treatment If patients or their family members do not want to continue to participate in the study during the study they will be considered as withdrawal If patients suffer from sudden malignant arrhythmia or cardiac arrest during the study resulting in death or transfer to other hospitals or other departments during the study patients will be excluded Data from dropped and excluded patients were not included in the final statistical analysis After the data of 269 patients were collected the study was concluded and the results and conclusions were derived by statistical analysis
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None